Lv2
160 积分 2023-07-21 加入
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
3小时前
已完结
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting Glypican 3 effectively control human hepatocellular carcinoma in mice
1个月前
已关闭
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation
1个月前
已完结
Letter to the Editor: The divergences in the efficacy of adjuvant transarterial chemoembolization for hepatocellular carcinoma: In-depth analysis and enlightenments
2个月前
已完结
肝细胞癌术后辅助治疗的现状与展望
1年前
已关闭
肝癌诊疗新进展：指南引领规范 创新赋能精准
1年前
已关闭
Ceramide synthase 3 affects invasion and metastasis of hepatocellular carcinoma via the SMAD6 gene
1年前
已完结
[Expert consensus on the clinical application of the markers of hepatitis B virus]
1年前
已完结
Syntaxin-6 mediated autophagy confers lenvatinib resistance in hepatocellular carcinoma
皖公网安备34019202002308
